The present invention provides the new form of formula (I) compound. The present invention relates to the form of compound (I), crystalline form and amorphous is related in particular to, it is amorphous more specifically to four kinds of crystalline forms and one kind. The invention further relates to the therapeutical uses for preparing the method for the form, the Pharmaceutical composition containing crystalline form and/or the amorphous compound and the form.本發明提供式（I）化合物的新的形態。本發明涉及化合物（I）的形態，具體地說涉及晶形和非晶形，更具體地說涉及四種晶形和一種非晶形。本發明進一步涉及製備所述形態的方法、含有晶形和／或非晶形的所述化合物的藥用組合物以及所述形態的治療用途。
